Sylvester Researchers study QoL During Immunotherapy Treatment – OncoDaily
Sylvester Researchers study QoL During Immunotherapy Treatment / cancer, Gilberto Lopes, immunotherapy treatment, Jose Lutzky, OncoDaily, Oncology, Patricia
Related Articles
Wafik El-Deiry: I Hope Severe Budget Cuts to NIH and NCI Can Be Avoided to Minimize Disruption to Research Progress – OncoDaily
Wafik El-Deiry: I Hope Severe Budget Cuts to NIH and NCI Can Be Avoided to Minimize Disruption to Research Progress / cancer, Cancer research, NCI,…
Bishal Gyawali: Is Life a Jigsaw Puzzle? – OncoDaily
Bishal Gyawali: Is Life a Jigsaw Puzzle? / Bishal Gyawali, cancer, cancer care, OncoDaily, Oncology
Katell Maguet: Unmet Needs of Young Colorectal Cancer Patients – A New European Study – OncoDaily
Katell Maguet: Unmet Needs of Young Colorectal Cancer Patients – A New European Study / Andi Carlan, BMC Gastroenterology, cancer, Change Katalyst, colorectal
Petros Grivas: Best of ASCO in Seattle – OncoDaily
Petros Grivas: Best of ASCO in Seattle / Binaytara, cancer, OncoDaily, Oncology, Petros Grivas, University of Washington and Seattle Cancer Care Alliance
Myeloma Paper of the Day, June 16th, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, June 16th, suggested by Robert Orlowski / Abderrazak El Yamani, Adrienne de Labarthe, Alexis Talbot, Arthur Bobin, Aurore Perrot,
PROTAC Targeting LZK Shows Promise for Treating HNSCC – NCI Center for Cancer Research – OncoDaily
PROTAC Targeting LZK Shows Promise for Treating HNSCC – NCI Center for Cancer Research / Amy L Funk, Anna A Marusiak, cancer, Carolyn C Woodroofe,…
7 Posts Not to Miss From the EHA 2025 – Nico Gagelmann – OncoDaily
7 Posts Not to Miss From the EHA 2025 – Nico Gagelmann / 30th EHA Annual Congress, EHA 2025, Hematology, Nico Gagelmann, The European Hematology…
Tumor Treating Fields Extend OS for Patients With Locally Advanced Pancreatic Cancer
The addition of tumor treating fields to first-line chemotherapy can extend overall survival without increasing systemic toxicity among patients with locally advanced pancreatic cancer, according…